introduction
Complementary and alternative medicine (CAM) has been defined as 'a group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine' [1] . In multiracial and multicultural Singapore, cancer patients are exposed to CAM from both western and eastern cultures, ranging from health supplements to traditional forms of medicine like Traditional Chinese Medicine (TCM), traditional Malay (Jamu) medicine and traditional Indian (Ayurvedic) medicine. A study conducted in Singapore [2] showed that the prevalence of CAM use was 76% which is higher compared with that reported in Western countries (25%-50%) [3] [4] [5] . Prevalence rates for CAM use may vary due to the differences in the way CAM is defined, the study population as well as methodology used. Hence, it is difficult to assess and compare CAM prevalence and usage across studies [6, 7] . Nevertheless, CAM therapies are generally used frequently and increasingly [8] .
This similar trend is seen among cancer patients. A systematic review reported usage of CAM in 7%-64% of adult cancer patients with an average prevalence of 31.4% [9] . Likewise, in a nation-wide survey done in Japan, 44.6% of cancer patients used CAM [10] . High prevalence of CAM use was also reported among Taiwanese homebound cancer patients (61%) [11] and in our local pediatric cancer patients (67.1%) [12] . Possible explanations to account for the high usage of CAM in cancer patients include to boost the immune system, relieve pain and control complications or side-effects related to disease or treatment [13] . Patients also viewed the use of CAM together with conventional treatment as a more integrative and holistic approach for the treatment of their cancer and associated side-effects [14] . Some patients may also use CAM due to its presumed action as an anticancer agent [15] [16] [17] . However, there is a lack of well-designed safety and efficacy studies evaluating CAM products, especially for products such as botanicals that have not been sufficiently characterized or standardized [18] . Hence, most reported results are not able to translate into clinical practice due to lack of proven clinical efficacy. Studies have shown that cancer patients who use CAM tend to be female, married, higher earners, better educated and those who have used CAM before their cancer diagnoses [8, 19] . Also, colorectal and breast cancer patients seem to be more likely to use dietary supplements as compared with lung cancer patients [20] .
Currently in Singapore, there is a lack of information addressing the prevalence and possible patient factors and their clinical characteristics that may influence CAM use among adult cancer patients. Hence, a study was conducted at National Cancer Centre (NCC), the largest ambulatory cancer center in Singapore, to (i) determine the prevalence of CAM use in adult cancer patients, (ii) identify the most commonly used CAM, (iii) estimate the acquisition costs of CAM and (iv) determine patient sociodemographics and their clinical characteristics influencing the use of CAM. The findings of this study can serve as a guide for health-care professionals to identify potential patients who may require advice on CAM and to provide appropriate counseling.
methodology design and procedure
This is a single-center, cross-sectional, study carried out at the Ambulatory Treatment Unit of NCC. Cancer patients were screened and assessed for study eligibility from October 2007 through March 2008. Patients were included if they met the following inclusion criteria: (i) at least 21 years of age or older, (ii) of either gender with a confirmed diagnosis of cancer regardless of tumor type, (iii) conversant in either English or Mandarin and (iv) willing to participate in the study. Patients were excluded if they were unable to give written consent, for example patients with cognitive impairment.
This study focuses on the use of oral CAM only. Using the categories of CAM under the National Center for Complementary and Alternative Medicine classification system [1] , 'Alternative Medical Systems' such as TCM and Ayurveda and 'biologically based therapies' such as dietary supplements and herbal supplements were included. Forms such as 'energy therapies', 'mind-body interventions' and 'manipulation and body-based methods' were excluded.
Our Institutional Review Board approved the study and all patients provided written informed consent. The survey was interviewer administered in either English or Mandarin by trained pharmacy students.
the questionnaire
Since there is no validated questionnaire available, one was drafted after literature review and evaluated by two oncology pharmacists, a biostatistician and a senior medical oncologist. It included the following information: (Figure 1 ). The main reasons cited for CAM usage were to boost immunity (53.7%) and for general health (16.7%). On the contrary, the top three reasons for not using CAM (n = 176) were fear of interferences with chemotherapy (24.4%), oncologists were against CAM use (22.2%) and lack of advice from oncologists regarding CAM (7.4%). Other reasons reported were that patients only wanted to take medications prescribed by their oncologists during anticancer therapy (5.7%) or that they are unable to afford CAM due to financial difficulties (4%).
Friends and other cancer patients were found to be the main sources of information regarding CAM therapies (52.4%), followed by recommendations from family members or relatives (16.3%). Only 3% of patients obtained information on CAM from talks or seminars organized by companies selling health products and overseas tours. About 7% reported that 
acquisition costs of CAM
Monthly expenditure on CAM products was highly varied. Most patients (67.0%) spent <SGD$300 (USD $217) a month on CAM and 15.9% were spending >SGD$500 (USD $362) a month. A minority of patients (7.5%) was unable to give an estimated cost of the CAM products as they were given by friends or family members.
characteristics of CAM user
Approximately half (46.3%) of the patients on CAM did not discuss the usage of CAM with their oncologists. The most common reasons cited were that CAM were viewed as harmless and not medicines (34.3%), oncologists did not ask about CAM use (26.7%) and fear that oncologists may discourage CAM use (17.1%). Among all characteristics, only race, education level and prior CAM use were found to be associated with CAM use (P < 0.05) ( Table 3) .
discussion
In this study, the prevalence of CAM use among our local adult cancer patients was found to be 56.3%, higher than the average prevalence reported from other adult studies [19, 21] . However, it was lower than the prevalence of use among the local general population [2] . Singapore has a racially and culturally diverse population exposed to both western and eastern forms of CAM. This could account for the increased awareness that may subsequently lead to CAM usage. In recent years, an increasing prevalence in self-care [22] would imply that patients might possibly develop greater interest in CAM. CAM information is generally regarded as 'empowering' as it broadens treatment and self-care options [23] .
One of the predominant forms of CAM used was TCM. This is not surprising since a large proportion of Asian patients seek traditional herbal medicine. Majority of patients in this study were Chinese. A study done among breast cancer patients in China found that 98% used TCM [24] . Similarly, in a Taiwanese study done among cancer patients, the complementary therapy most often used was TCM [11] . However, other forms of traditional medicines such as Ayurveda and Jamu medicine were not as popular as compared with TCM. Only 0.4% of patients are currently using Ayurvedic medicine and 2.8% of patients used Jamu medicine before their cancer diagnoses. The use of TCM raises special concern; particularly since more than half (53.6%) the patients on TCM were taking herbs. Herbs contain a variety of different chemicals, most of which have not been documented [25] .
A majority of patients felt that the use of CAM would boost their immunity or give them general good health. Only a small percentage (3.5%) used CAM to 'prolong survival' or to 'hope to cure cancer'. These responses showed that local patients primarily viewed CAM as 'complementary' rather than 'alternative' and understood that CAM has a supportive rather than curative role in the management of cancer. Hence, it meant that most patients would not reject conventional treatment and rely solely on CAM therapies.
It was also found that 22.2% of patients interviewed made decisions not to take certain types of CAM, for example TCM, upon advice from their oncologists. However, almost half of the patients felt that it was unnecessary to discuss the use of CAM with their oncologists since they were 'not medicines' and were harmless'. This was similar to other studies where CAM users were found to view CAM as 'safe' [26] and 'holistic' [27] . Although there is some level of awareness of the potential dangers of CAM use and the interactions that they may have with anticancer agents, more has to be done to educate our local patients in this area. Several reasons have been reported in literature for patients' resistance to discuss CAM with their doctors, including clinician indifference or opposition toward CAM use, clinician emphasis on scientific evidence and patients' anticipation of a negative response from their clinicians [28] . Interestingly, in this study, 7% of patients reported that a health professional recommended CAM products to them. Although this was a small percentage, it could reflect that health-care professionals' attitudes toward CAM have changed. In a survey carried out at an academic medical center to evaluate physicians' attitudes toward CAM and their knowledge of specific therapies, 57% of physicians thought that incorporating CAM therapies would have a positive effect on patient satisfaction. However, most were not comfortable in counseling their patients about CAM [29] . Hence, there is a need to increase the awareness among health-care professionals on the availability of systematic, evidence-based information on popular dietary supplements used by cancer patients and herbdrug interactions in oncology.
With the widespread availability and use of the Internet, it has been observed that minority of patients obtained CAM products from overseas sources, for example via the Internet or when they traveled abroad. These CAM products are not subject to regulation by our local health authorities. In the United States, product contamination and inconsistency of TCM have been reported [30] . CAM products must be free from contamination especially since cancer patients have lower immunity and possibly impaired kidney or liver function.
Friends, other cancer patients and family members have shown to be the main sources of information regarding CAM therapies and it was observed that patients tend not to verify information received from these sources. Indeed, partners, family and friends have shown to play a significant part in influencing decisions about CAM use in cancer patients [31] . Surprisingly, not many patients used the Internet as a source of information on CAM. A minority of patients obtained information on CAM products from talks or seminars organized by companies selling health products. Information obtained from such talks may not be fully accurate or reliable since they may be biased toward the products sold by the company. More importantly, 'scientific' terms used in these talks may mislead patients to think that these products have proven efficacy. Hence, patients need to be educated to prevent injudicious use of CAM.
Approximately three-quarter of the users felt that CAM was effective for the purpose that they are taking it for. CAM effectiveness cannot be easily proven since often patients were not only on multiple forms of CAM but also received conventional cancer treatment at the same time. Since the effects of CAM products are often not clearly evident, there may be a psychological element involved in determining its efficacy. About one-fifth of the CAM users are unsure of the effectiveness of CAM. One reason given was that it was difficult to discern the effects of CAM as the patient had been taking CAM products before cancer diagnosis and has not stopped taking since. Some patients thought that it was 'better to have additional coverage' and that there was 'no harm trying'.
The characteristics of a CAM user found in this study were different from that reported in other studies. In the literature, CAM use among cancer patients has revealed a common trend that these users tend to be female, married people, higher earners, better educated and those who have used CAM before cancer diagnoses [19, 21] . However, our study demonstrated that only race, education level and prior CAM use were associated with CAM use. Patients in this subgroup may have greater exposure to CAM and positive experiences with previous CAM use.
Sixteen percent of patients were willing to spend >SGD$500 (USD$362) per month on CAM products. This may add to the financial burden of treatment for our cancer patients. Besides, the safety and efficacy of CAM products have not yet been established. Hence, patients need to be educated on the cautious use of CAM during treatment and to always consult and inform health-care professionals before CAM use.
limitations
There were several limitations to this study. As patients were asked to recall the types of CAM they had used before diagnosis as well as the types of CAM they are currently using, recall bias may be present. For patients who were unable to recall all the types of CAM that they were taking, especially if they were on multiple CAM, follow-up with patients could have been carried out. However, due to time constraints, this was not done in this study. There were limitations in the inclusion/exclusion criteria as well. Patients on trial and who were no longer on active chemotherapy treatment were not excluded. This may lead to bias as patients on trial would be instructed not to take CAM whereas the latter may be reassured that it was acceptable for them to take CAM. However, it has been found that many patients used herbal and dietary supplements while participating in clinical trials [32, 33] . The interviews were conducted by multiple personnel, giving rise to the possibility of interviewer bias. However, interinterviewer variation was not found to be statistically significant (P > 0.05) with regard to the distribution of CAM and non-CAM users.
conclusions
In view of the considerably high prevalence of CAM use among our local cancer patients, the issues related to CAM usage can no longer be avoided or simply ignored. Race, education level and prior CAM have found to be significantly associated with CAM use. Given the limited consultation time that physicians have with their patients, these predictors may be a useful guide to physicians in identifying patients who require more advice and counseling. Patients also often expect their oncologists to initiate the provision of advice concerning CAM. Hence, the onus is on health-care professionals to actively elicit information regarding CAM use and to provide relevant advice. The need for more patient education on the safe use of CAM is apparent, both in the area of potential CAM-anticancer drug interactions as well as on reliable sources of information on CAM. Future studies can focus on specific groups of patients, for example patients with a particular cancer type in order to gain greater insight into the possible interactions that may original article Annals of Oncology
